Depression in Parkinson's disease.

被引：36
|
作者：
Zesiewicz T.A. [1 ]
Hauser R.A. [1 ]
机构：
[1] Parkinson's Disease and Movement Disorders Center, University of South Florida College of Medicine, 4 Columbia Drive, Tampa, 33606, FL
来源：
Current Psychiatry Reports | 2002年 / 4卷 / 1期
关键词：
Depressive Symptom; Fluoxetine; Paroxetine; Sertraline; Selegiline;
D O I：
10.1007/s11920-002-0016-7
中图分类号：
学科分类号：
摘要：
Depression is common in Parkinson's disease (PD), and its identification and treatment are critically important in disease management. Despite depression's high prevalence and major impact on patient quality of life, questions remain regarding its epidemiology and preferred treatment. The authors of this paper summarize available information on the epidemiology of depression in PD, review treatment options, and discuss possible interactions between antidepressants and other agents. This information may help guide clinical treatment and define the need for further studies.
引用
收藏
页码：69 / 73
页数：4
相关论文
共 50 条
  • [21] Evolution of Parkinson's disease. Conclusions
    Garcia-Ruiz, Pedro J.
    [J]. REVISTA DE NEUROLOGIA, 2010, 50 : S21 - S21
  • [22] Neurological rehabilitation and Parkinson's disease.
    Auff, E
    Hochschorner, G
    [J]. NEUROPSYCHIATRIE, 1995, 9 : S40 - S41
  • [23] Role of TNFα in Parkinson's disease.
    Gemma, C
    Catlow, B
    Hudson, C
    Samec, A
    Bickford, PC
    [J]. EXPERIMENTAL NEUROLOGY, 2003, 181 (01) : 92 - 92
  • [24] Gene discovery in Parkinson's disease.
    Kallarakal, AT
    Rowland, AM
    Jacobowitz, DM
    [J]. FASEB JOURNAL, 1999, 13 (05): : A1103 - A1103
  • [25] Electroconvulsive therapy in Parkinson's disease.
    Faber, R
    [J]. JOURNAL OF ECT, 2001, 17 (01) : 78 - 78
  • [26] Psychiatric issues in Parkinson's disease.
    Leroi, Iracema
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 21 (09) : 902 - 902
  • [27] Treatment of Parkinson's disease. Duodopa®
    Valldeoriola, F.
    [J]. REVISTA DE NEUROLOGIA, 2010, 50 : S34 - S36
  • [28] Psychosocial aspects of Parkinson's disease.
    Scholz, H
    Barolin, GS
    [J]. NEUROPSYCHIATRIE, 1995, 9 : S38 - S39
  • [29] Neurocognitive deficits in Parkinson's disease.
    Zakzanis, KK
    Freedman, M
    [J]. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 1999, 14 (01) : 69 - 69
  • [30] Segregation analysis of Parkinson's disease.
    Zareparsi, S
    Taylor, TD
    Larson, K
    Nutt, J
    Harris, EL
    Payami, H
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A216 - A216
12345